TCF4
Transcription factor 4
Also known as: bHLHb19, E2-2, ITF2, ITF2_HUMAN, SEF2-1B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15884
- Gene
- TCF4
- Ensembl
- ENSG00000196628
- Chromosome
- 18
- Canonical length
- 667 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
This gene encodes transcription factor 4, a basic helix-loop-helix transcription factor. The encoded protein recognizes an Ephrussi-box ('E-box') binding site ('CANNTG') - a motif first identified in immunoglobulin enhancers. This gene is broadly expressed, and may play an important role in nervous system development. Defects in this gene are a cause of Pitt-Hopkins syndrome. In addition, an intronic CTG repeat normally numbering 10-37 repeat units can expand to >50 repeat units and cause Fuchs endothelial corneal dystrophy. Multiple alternatively spliced transcript variants that encode different proteins have been described. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
667 residues, UniProt reviewed canonical sequence.
>P15884|TCF4
1 MHHQQRMAAL GTDKELSDLL DFSAMFSPPV SSGKNGPTSL ASGHFTGSNV EDRSSSGSWG
61 NGGHPSPSRN YGDGTPYDHM TSRDLGSHDN LSPPFVNSRI QSKTERGSYS SYGRESNLQG
121 CHQQSLLGGD MDMGNPGTLS PTKPGSQYYQ YSSNNPRRRP LHSSAMEVQT KKVRKVPPGL
181 PSSVYAPSAS TADYNRDSPG YPSSKPATST FPSSFFMQDG HHSSDPWSSS SGMNQPGYAG
241 MLGNSSHIPQ SSSYCSLHPH ERLSYPSHSS ADINSSLPPM STFHRSGTNH YSTSSCTPPA
301 NGTDSIMANR GSGAAGSSQT GDALGKALAS IYSPDHTNNS FSSNPSTPVG SPPSLSAGTA
361 VWSRNGGQAS SSPNYEGPLH SLQSRIEDRL ERLDDAIHVL RNHAVGPSTA MPGGHGDMHG
421 IIGPSHNGAM GGLGSGYGTG LLSANRHSLM VGTHREDGVA LRGSHSLLPN QVPVPQLPVQ
481 SATSPDLNPP QDPYRGMPPG LQGQSVSSGS SEIKSDDEGD ENLQDTKSSE DKKLDDDKKD
541 IKSITSNNDD EDLTPEQKAE REKERRMANN ARERLRVRDI NEAFKELGRM VQLHLKSDKP
601 QTKLLILHQA VAVILSLEQQ VRERNLNPKA ACLKRREEEK VSSEPPPLSL AGPHPGMGDA
661 SNHMGQMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCF4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- placenta: 27 nTPM
- cervix: 27 nTPM
- cerebral cortex: 24 nTPM
- ovary: 23 nTPM
- smooth muscle: 23 nTPM
- endometrium: 22 nTPM
Single-cell type
- pdcs: 2,704 nCPM
- vascular endothelial cells: 1,659 nCPM
- oligodendrocyte progenitor cells: 1,148 nCPM
- fibro-adipogenic progenitors: 1,091 nCPM
- bergmann glia: 887 nCPM
- ependymal cells: 860 nCPM
Immune cell
- plasmacytoid DC: 561 nTPM
- memory B-cell: 174 nTPM
- naive B-cell: 148 nTPM
- myeloid DC: 21 nTPM
- total PBMC: 11 nTPM
- NK-cell: 11 nTPM
Brain region
- cerebellum: 238 nTPM
- hippocampal formation: 167 nTPM
- cerebral cortex: 159 nTPM
- white matter: 135 nTPM
- basal ganglia: 128 nTPM
- medulla oblongata: 116 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TCF4.
Disease | AllUniProt
Conditions TCF4 is implicated in, by any mechanism.
- Pitt-Hopkins syndrome (PTHS) MIM:610954
- Corneal dystrophy, Fuchs endothelial, 3 (FECD3) MIM:613267
Disease | GeneticClinVar
286 pathogenic / likely-pathogenic of 1,272 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pitt-Hopkins syndrome
- Inborn genetic diseases
- Corneal dystrophy, Fuchs endothelial, 3
- TCF4-related disorder
- Intellectual disability
ReferencesPubMed · IEDB
Publications for TCF4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.
2021 · JAMA Neurol · RCR 2.5 · 41 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.1
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- nervous system development
- positive regulation of DNA-templated transcription
- positive regulation of neuron differentiation
- positive regulation of transcription by RNA polymerase II
- protein-DNA complex assembly
- regulation of transcription by RNA polymerase II
Molecular functions
- beta-catenin binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- E-box binding
- identical protein binding
- protein heterodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- TFIIB-class transcription factor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCF4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCF4 as an antibody target. Whether an autoantibody or antibody against TCF4 could matter depends on whether native TCF4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCF4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCF4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...